Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Other Working Capital Changes (2020 - 2025)

Ovid Therapeutics' Other Working Capital Changes history spans 6 years, with the latest figure at -$1.7 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 428.75% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached -$1.3 million, down 7.22%, while the annual FY2025 figure was -$1.3 million, 7.22% down from the prior year.
  • Other Working Capital Changes reached -$1.7 million in Q4 2025 per OVID's latest filing, down from -$362000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $13.0 million in Q3 2021 to a low of -$12.3 million in Q2 2021.
  • Average Other Working Capital Changes over 5 years is -$15028.8, with a median of -$77532.5 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: tumbled 4763.84% in 2021, then skyrocketed 220.16% in 2022.
  • A 5-year view of Other Working Capital Changes shows it stood at -$649747.0 in 2021, then surged by 220.16% to $780706.0 in 2022, then skyrocketed by 107.89% to $1.6 million in 2023, then tumbled by 119.72% to -$320000.0 in 2024, then plummeted by 428.75% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OVID's Other Working Capital Changes are -$1.7 million (Q4 2025), -$362000.0 (Q3 2025), and $658000.0 (Q2 2025).